Interaction of dexamethasone and montmorillonite - Adsorption-degradation process by Forteza González, M. et al.
Applied Clay Science, 4 (1989) 437-448 437 
Elsevier Science Publishers B.V., Amsterdam - - Printed in The Netherlands 
I n te ract ion  of  Dexamethasone  and 
Montmor i l l on i te  - Adsorpt ion -Degradat ion  
P rocess  
M. FORTEZA 1, E. GAL~,N 1 and J. CORNEJO 2 
1Departamento deGeologia, Facultad de Quimica, Universidad e SeviUa, Apdo. 553, 
41071 Sevilla (Spain) 
2Instituto de Recursos Naturales yAgrobiologia, C.S.I.C., Apdo. 1052, 41080 SeviUa (Spain) 
(Received February 1, 1988; accepted after revision August 8, 1988 )
ABSTRACT 
Forteza, M., Galdn, E. and Cornejo, J., 1989. Interaction ofdexamethasone and montmorillonite 
- adsorption-degradation pr cess. Appl. Clay Sci., 4: 437-448. 
The degradation ofdexamethasone i  an aqueous suspension of montmorillonite s ems to be 
the result of two apparent first order reactions. The dexamethasone content, as determined by 
high-pressure liquid chromatography (HPLC), rapidly decreases from 50 to 4.7 gg/ml after 24 h, 
and then remains almost constant during 168 h. The first stage of the decomposition is mainly 
consistent with an adsorption process, while the second one is characterized bya slow degradation 
of dexamethasone remaining insolution. 
X-ray diffraction (XRD) and infrared (IR) studies howed the presence of dexamethasone 
molecules adsorbed in the interlayer space of montmorillonite, with the basal spacing being con- 
sistent with an orientation ofthe plane of the rings parallel to that of the silicate sheets. Desorp- 
tion studies showed a slow release of the dexamethasone from the interlayer space of 
montmorillonite. 
INTRODUCTION 
The swelling capacity of montmorillonite, as well as its adsorption, suspen- 
sion-forming and gel-forming properties, makes it suitable as an excipient in 
pharmaceutical uses. The incorporation of various grades of montmorillonite 
in the matrix of solid forms of dosage such as disintegrants, binders and lubri- 
cants was studied by Wai et al. (1966). Other reports dealing with the use of 
montmorillonite as a "disintegrating" agent were performed by Gross and 
Becker (1952) and Firouzabadian and Huyck (1954). 
Recently, the ability of montmorillonite to form interlayer complexes with 
organic molecules of pharmaceutical interest has been widely studied. Mc- 
Ginity and Lach (1977) and Sdnchez-Camazano et al. (1980a,b and 1987) 
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have suggested that montmorillonite could be used in designing sustained-re- 
lease formulations as a result of drug-montmorillonite interaction. 
Nevertheless, most investigations in this field have been mainly carried out 
on cationic drugs, as well as on weak bases (Porubcan et al., 1978; Browne et 
al., 1980a,b), while minor attention has been paid to the interaction of neutral 
or polar drugs with clays (Porubcan et al., 1979; Cornejo et al., 1980; Hermosfn 
et al., 1981 ). Such interactions can result in complex adsorption-degradation 
processes. 
The aim of this paper is to investigate if the interaction of montmorillonite 
with dexamethasone could lead to changes in the bioavailability of this drug. 
Dexamethasone is one of the most powerful anti-inflammatory drugs which is 
orally or topically administered because of its minimal mineral-corticoid prop- 
erties. This neutral drug is known to degrade by an oxidation mechanism that 
produces elimination or transformation f the C-17 dihydroxiacetone side chain 
(Cohen, 1973). For the above-mentioned purpose, adsorption-desorption and
the profile of the degradation of the drug in presence of montmorillonite were 
investigated in an attempt to elucidate the mechanism responsible for these 
processes. 
EXPERIMENTAL 
Materials 
All chemicals were high-purity or reagent grade. The sodium montmorillon- 
ite (SWy-1) from Clay Mineral Repository, was used as received. An X-ray 
diffractogram indicated that montmorillonite was the major mineral present 
although small amounts of quartz, calcite and feldspar were found. The dexa- 
methasone used was obtained from Sigma Chemical Co. 
Dexamethasone assay 
The dexamethasone concentration was determined by high-pressure liquid 
chromatography (HPLC). The method was slightly modified from that used 
by Cornejo et al. (1980) for the analysis of hydrocortisone and its degradation 
products. The liquid chromatograph was an ALC 501 from Waters Associates, 
equipped with an ultraviolet (UV) detector operating at 240 nm and an uni- 
versal injector. A microparticulate reversed-phase column (Nova-Pak C ls) was 
used with acetonitrile:water (40:60) as the mobile phase. The operating pa- 
rameters were: flow rate 1 ml/min; pressure 2000-2200 psi; room temperature; 
injection volume 10 ttl and UV attenuator 0.2 aufs. 
Changes in the A-ring, mainly due to photolitic degradation, were monitored 
by UV spectrometry at 240 nm in a Pye-Unicam model SP 1800 
spectrophotometer. 
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The structural formula of dexamethasone is: 
~ H20H 
CH C ~0 
Kinetic studies 
The montmorillonite concentration was selected as representative of the 
range usually used for clays in pharmaceuticals; the dexamethasone concen- 
tration was below the solubility limit, 10 mg/100 ml at 23 ° C (Cohen, 1973 ), 
to ensure complete solubility during kinetic studies. Thus, 100 mg of mont- 
morillonite were mixed with 30 ml of an aqueous olution of dexamethasone 
(50/~g/ml) in a 50-ml stoppered centrifuge tube. The samples were aged in a 
shaker-incubator at 23, 35 and 55 ° C. At appropriate intervals, aliquots were 
centrifuged at14,000 rpm and the supernatant liquid was filtered and analyzed 
by HPLC and UV. The pH of each suspension was measured and found to be 
8.7 at whatever the sampling interval. 
Aqueous olutions of dexamethasone (50/~g/ml) were made up at pH 6.0. 
Some were adjusted to pH 8.7 with sodium hydroxide. The solutions were aged 
along with the clay-drug suspensions and served as controls. 
Adsorption-desorption isotherm 
Dexamethasone-montmorillonite suspensions were prepared as described, 
but dexamethasone concentrations of 1-50/~g/ml and 25 mg of sodium mont- 
morillonite were used. The suspensions were equilibrated in the shaker-incu- 
bator at constant temperature (23 °C) for 24 h. The pH of each suspension 
was the same as for kinetic studies. 
Desorption studies were performed by recovering the equilibrated clay from 
adsorption study and resuspending the clay in sufficient water at pH 8.7 to 
achieve the original concentration. This procedure was repeated six times. 
The amount of dexamethasone adsorbed or desorbed was calculated from 
the change in dexamethasone concentration of the supernatant after 
equilibration. 
In order to study the pH influence on adsorption, dexamethasone-mont- 
morillonite suspensions at pH 2.4, 4.3, 6.2, 8.7 and 10.0 were prepared as for 
the adsorption isotherm, with a dexamethasone concentration of 50 #g/ml. 
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Each suspension was adjusted to the desired pH with hydrochloric acid or so- 
dium hydroxide, respectively. 
X-ray diffraction 
For X-ray diffraction studies, or iented aggregates of sodium montmori l lon-  
ite and of the unwashed drug-montmor i l lon i te  complex were used. The  ori- 
ented aggregate was prepared by drying an appropriate volume of suspension 
on a glass slide. Di f fractograms were run at room temperature and after heat- 
ing at 110 ° C on a Siemens D-500 Kristalloflex apparatus, using Cu Ks radiation. 
IR analysis 
Self-support ing films were prepared by pipett ing appropriate volumes of 
either montmori l loni te or montmor i l lon i te -dexamethasone uspensions onto 
a sheet of polyethylene t rephthalate (Mylar)  and air-drying at room temper-  
ature (Porubcan et al., 1978). 
Dexamethasone was prepared for IR analysis as potassium bromide pellets. 
The  spectra were recorded on a Nicolet 5DXE spectrophotometer.  
RESULTS AND DISCUSSION 
Dexamethasone exhibited a very slow degradation i aqueous olution at pH 
6.0 which is consistent with previously reported stabil ity results (Hansen and 
Bundgaard,  1980). Dexamethasone degradation increases with both pH or 
temperature (Table I).  The  dexamethasone content  of an aqueous olution at 
pH 8.7 and 23°C, as determined by HPLC,  decreased from 50 to 47.6 #g/ml  
after aging for 168 h (Fig. lb ) ,  while no appreciable degradation was observed 
by UV analysis. These data, as well as the peaks present in the high-pressure 
TABLE I 
Stability of dexamethasone i  presence of montmorillonite 
Temp. Aqueous ol. r *l Montmorillonite susp. at pH 8.7 
at pH 6.0; 
k, h -1 kl, h -1 r .1 k2, h -1 r*' 
23°C 1.66.10 -5 0.9993 53.48"10 -3 0 .9995 6.15"10 .4 0.9965 
35°C 6.05.10 -° 0.9973 27.00"10 -3 0 .9901 10.40"10 -4 0.9897 
55 ° C 3.95-10 -4 0.9989 15.90" 10 -3 0 .9957 28.20" 10 -4 0.9899 
pH 8.7 and 
23 ° C 1.33" 10 -4 0.9975 - - 
• lr = correlation coefficient. 
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Fig. 1. Stability of dexamethasone in the presence of montmorillonite, a) Relative concentration 
of dexamethasone and degradation products in a montmorillonite suspension at pH 8.7 during 
aging at 23 ° C: 1 = dexamethasone  (D);  2 = acid degradation product (A); 3 = neutral degradation 
product (N) .  b)  Change in dexamethasone concentration of aqueous phase {theory = 50 #g/ml )  
at pH 8.7 and 23°C: 4=dexamethasone solution by HPLC; 5=montmorillonite suspension by 
HPLC;  6= montmorillonite suspension by UV (degradation products concentration is also mea- 
sured by UV) ;  7 = CBD-t reated  montmorillonite suspension by HPLC.  
liquid chromatogram, indicate that dexamethasone degradation is mainly due 
to oxidation of the C-17 dihydroxyacetone side chain, giving rise to two major 
degradation products, acidic and neutral in character. A similar degradation 
pathway of prednisolone was previously described by Guttman and Meister 
(1958). A plot of the logarithm of dexamethasone concentration versus time 
gave a straight line indicating that degradation of dexamethasone, at any pH 
studied, apparently occurs by first-order kinetics (Table I). Hansen and Bund- 
gaard (1980) found similar kinetics for hydrocortisone degradation 
(8 < pH < 12), although an intermediate step is the formation of the corre- 
sponding glyoxal. 
In a montmorillonite suspension, at pH 8.7 and 23 ° C, the dexamethasone 
content of the aqueous phase decreased from 50 to 4.7 #g/ml during the first 
24 h, and very slowing during the next 144 h (Fig. lb). The HPLC and UV 
analyses of the dexamethasone-montmorillonite suspension suggested that 
dexamethasone is adsorbed by montmorillonite, producing an immediate de- 
crease in the dexamethasone concentration. This hypothesis is confirmed by 
analysis of the peaks appearing in the high-pressure liquid chromatogram. With 
the HPLC system used, dexamethasone has a retention time of 2.75 min, while 
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the two initial degradation products have retention times of 0.90 and 2.42 min. 
The peak height of dexamethasone dropped initially but changed slightly on 
aging (Fig. la). However, the heights of the peaks corresponding to the two 
initial degradation products, were very low and increased only very little on 
aging. The initial decrease of dexamethasone concentration, asdetermined by 
HPLC and UV analysis (Fig. lb) seems to be due to adsorption of dexameth- 
asone by montmorillonite rather than to accelerated egradation of 
dexamethasone. 
The relationship between dexamethasone concentration r its logarithm and 
time, was not linear at any temperature studied. To characterize the dexa- 
methasone degradation rate in the presence of montmorillonite, the degrada- 
tion profile (Fig. lb) was treated as consisting of an initial first-order phase, 
characterized by kl, which was followed by a slower first-order stage charac- 
terized by k2. Good linear correlations were obtained for both phases (Table 
I ). The first stage could be consistent with a slow degradation ofdexametha- 
sone together with a dexamethasone adsorption by the clay, while the second 
one is thought mainly to be a degradation process. 
Similar studies carried out by Cornejo et al. (1980) and Hermosln et al. 
(1981) for the interaction of hydrocortisone with sepiolite and palygorskite 
indicated that adsorbed surface iron and/or structural ferric iron was respon- 
sible for accelerated degradation of hydrocortisone in the presence of those 
clays. On the other hand, it has been proved that traces of other metal ions 
(Cu 2+, Fe 3+ and Ni 2+ ) present as impurities in the buffer reagents could also 
produce an accelerated degradation ofthe C-17 dihydroxiacetone side chain of 
corticosteroids (Hansen and Bundgaard, 1980). 
In the present study, k2 values (Table I) are greater, at any temperature 
studied, than the corresponding k values obtained for aqueous olution of dex- 
amethasone. It could be hypothesized that accelerated degradation of dexa- 
methasone in presence of montmorillonite could be catalyzed by the surface 
(0.72 mg/g) and structural (25.6 mg/g) iron of montmorillonite, whose con- 
tent is similar to that present in palygorskite (Forteza, 1987). To verify this 
hypothesis, a portion of montmorillonite was treated by the citrate-bicarbon- 
ate-dithionate (CBD) method to extract non-structural ferric iron. Dexa- 
methasone was much more stable in a suspension of treated montmorillonite, 
although the degradation was substantially greater than that occurring in an 
aqueous dexamethasone solution (Fig. lb). 
To evaluate the amount of dexamethasone adsorbed by montmorillonite the 
adsorption isotherm at pH 8.7 and 23 °C was determined (Fig. 2 ). The initial 
slope of the curve suggests an isotherm of "S" type according to the classifi- 
cation of Giles et al. (1960), which is indicative of vertical orientation of sur- 
face adsorbed molecules. The second inflection point and the short plateau 
suggested that formation of a "monolayer" has been reached. The adsorption 
data above the second inflection point gave a good linear fit when the theoret- 
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Fig. 2. Adsorption isotherm for dexamethasone by montmoril lonite: qx= amount of dexametha- 
sone adsorbed; Ce = equilibrium concentration. 
ical Langmuir equation was applied (r--0.9987). The maximum amount of 
dexamethasone adsorbed by montmorillonite, asdetermined by the slope of 
the Langmuir plot, was 169.1/~mol/g. 
The amount of dexamethasone that could be theoretically adsorbed by 
montmorillonite, calculated on the basis of external (40 m2/g) and total (748 
m2/g) surface area (Hermosln, 1978), are 92.4/~mol/g and 1.72 mmol/g, re- 
spectively. The experimental data obtained from the adsorption isotherm is 
almost double than that of the external surface. So, it is hypothesized that 
dexamethasone at low concentrations is weakly surface-sorbed bymontmoril- 
lonite. As concentration i creases, drug molecules are able to penetrate the 
interlayer space of montmorillonite. In this case, a no completed monolayer 
could be formed, probably including some water molecules. 
Desorption studies (Fig. 3) confirmed the above proposed mechanism. De- 
sorption from samples corresponding to the initial slope of the isotherm was 
complete after three washings with water at pH 8.7. As the amount of dexa- 
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Fig. 3. Percentage ofdexamethasone desorbed from equilibrated montmorillonite-dexamethasone 
complex by water washings: /=from qz=9.46 #mol/g; 2=from qz=47.41 Bmol/g; 3=from 
q.-- 100.19/lmol/g (g.-- amount of dexamethasone adsorbed). 
methasone adsorbed increased, esorption became slower and incomplete. Only 
47% of dexamethasone was recovered after six washings with water. This de- 
sorption profile could be explained on the basis of the large size of dexameth- 
asone molecules. These could be trapped in the interlayer space of montmoril- 
lonite making desorption difficult due to a steric impediment. No degradation 
products were found by HPLC analysis during desorption studies. 
The adsorption of dexamethasone was examined by X-ray diffraction. The 
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d(001) spacing of an oriented examethasone-montmorillonite aggr gate after 
heating at 110°C was found to be 13.93 h, (Fig. 4b ). This basal spacing is close 
to the theoretically calculated if 9.7 ,h, and 4.3 A are assumed for the basal 
spacing of completely dehydrated montmorillonite and the height of dexa- 
methasone molecule perpendicular to the plane of the rings, respectively 
i _ l . A _~__  
2?  ° 19 ° I I ~ 2 e 
CUKc  
Fig. 4. X-ray diffractogram of oriented aggregates after heating at 110 °C of: a) montmorillonite; 
and b ) an unwashed dexamethasone-montmorillonite compl x ( Q = quartz; F= feldspar). 
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Fig. 5. IR spectra of: a ) dexamethasone in a potass ium bromide pellet; b ) a film of montmor i l lon-  
ite; and c ) a film of equi l ibrated examethasone-montmor i l l on i te  suspension at pH 8.7. 
(Forteza, 1987). These data suggested that dexamethasone molecules pene- 
trate the interlayer space of montmorillonite with a flat orientation, i.e., the 
mean plane of the steroidal skeleton being parallel to the mineral sheets. 
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The montmorillonite-dexamethasone complex showed abetter ordered if- 
fractogram than that of the untreated sample (Fig. 4). However, the upper 
orders (3.08 and 4.98 ,h,) corresponding to the basal reflection were not inte- 
gral, indicating an irregular distribution of dexamethasone and water mole- 
cules around the interlayer cations, throughout different sheets. 
An X-ray diffractogram of the dexamethasone-montmorillonite complex 
after six washings with water at pH 8.7, showed the same basal spacing (13.98 
,£,) as for unwashed sample. This result, together with those obtained by de- 
sorption studies, suggest the presence of dexamethasone molecules in the in- 
terlayer space of the clay, indicating a slow desorption profile for this drug. 
The IR spectrum of the montmorillonite-dexamethasone system shows rel- 
atively weak drug absorption bands (Fig. 5c) and confirms that the drug has 
been adsorbed by the clay. The 3400 cm-1 band of dexamethasone is com- 
pletely hidden by the OH-stretching band of the interlamellar water (3420 
cm- 1 ). However, two small bands at 2962 and 2886 cm- 1 due to CH-stretching 
vibrations appear in this spectrum. In addition, a big band composed by a 
shoulder at 1700 cm-1 corresponding to the carbonyl-stretching vibration of 
the C-17 dihydroxiacetone side chain, and a peak at 1660 cm -1 due to the 
carbonyl-stretching vibration of the C-3 dexamethasone A-ring associated with 
the 1630 cm- 1 OH-stretching band of interlamellar water, also are present. 
The X-ray diffraction, IR spectroscopy and adsorption-desorption data re- 
veal that the molecules of the drug are adsorbed in both external and internal 
surface of the clay. Much less than one monolayer of dexamethasone molecules 
is thought o be associated with interlamellar water molecules into the inter- 
layer space of the clay. These molecules eem to be randomly distributed 
throughout different clay sheets. 
The amount of dexamethasone adsorbed was similar at any pH studied 
(2.4 < pH < 10.0). The maximum dexamethasone adsorbed (160 pg/ml) was 
obtained between pH 2 and 4, probably due to a more protonated form of the 
A1OH and SiOH groups of the crystal borders, favouring hydrogen bonding 
between dexamethasone carbonyl groups and the clay surface. 
CONCLUSIONS 
The results of this study suggest that the catalytic influence of surface and 
structural ferric iron present in montmorillonite (Forteza, 1987), on the deg- 
radation pattern of the C-17 dihydroxyacetone side chain of corticosteroids is 
less than that observed for other clay minerals, such as palygorskite and se- 
piolite (Cornejo et al., 1980; Hermosln et al., 1981 ) probably due to a greater 
amount of drug adsorbed by montmorillonite. In addition, the formation of a 
dexamethasone-montmorillonite complex results in a reversible process with 
a slow and extended rug desorption. 
In conclusion, montmorillonite should be considered as a good pharmaceut- 
448 
ical excipient for designing oral or topical solid forms including relatively polar 
drugs subject o oxidative degradation. Furthermore, the drug-excipient inter- 
action, between corticosteroids and montmorillonite, could be successfully em- 
ployed in sustained-release formulations. 
REFERENCES 
Browne, J.E., Feldkamp, J.R., White, J°L. and Hem, S.L., 1980a. Acid-base quilibria of tetracyc- 
line in sodium montmorillonite suspensions. J. Pharm. Sci., 69: 811-815. 
Browne, J.E., Feldkamp, J.R., White, J.L. and Hem, S.L., 1980b. Potential of organic cation- 
saturated montmorillonite astreatment for poisoning by weak bases. J Pharm. Sci., 69: 1393- 
1395. 
Cohen, E.M., 1973. Dexamethasone. In: K. Florey (Editor), Analytical Profile of Drug Sub- 
stances, Vol. 2. Academic Press, New York, N.Y., pp. 164-197. 
Cornejo, J., Hermos~n, M.C., White, J.L., Peck, G.E. and Hem, S.L., 1980. Oxidative degradation 
of hydrocortisone in presence of attapulgite. J. Pharm. Sci., 69: 945-948. 
Firouzabadian, A. and Huyck, C.J., 1954. Some recently developed chemicals as disintegrating 
agents for compressed tablets. J Am. Pharm. Assoc., Sci. Ed., 43: 248-250. 
Forteza, M., 1987. Estudio de al interaccion de dexametasona con sepiolita, palygorskita y mont- 
morillonita. Ph.D. Thesis, Univ. of Sevilla, Sevilla, 227 pp. 
Giles, C.H., McEwan, T.H., Nakhwa, S.N. and Smith, D., 1960. Studies on adsorption, Part IX. 
A system of classification ofsolution adsorption isotherms, and its use in diagnosis of adsorp- 
tion mechanisms and in measurement of specific surface area of solids. J. Chem. Soc., pp. 3973- 
3993. 
Gross, H.M. and Becker, C.H., 1952. A comparative study of tablet disintegrating a ents. J Am. 
Pharm. Assoc., Sci. Ed., 41: 157-161. 
Guttman, D.M. and Meister, P.D., 1958. The kinetics of the base-catalyzed degradation ofpred- 
nisolone. J Am. Pharm. Assoc., Sci. Ed., 47: 773-778. 
Hansen, J. and Bundgaard, H., 1980. Studies on the stability of corticosteroids, III. Separation 
and quantitation of hydrocortisone and its degradation products by high-performance liquid 
chromatography. Arch. Pharm. Chem., 8: 91-99. 
Hermosfn, M.C., 1978. Estudio de la adsorci6n del pesticida Clordimeform pro minerales de la 
arcilla. Ph.D. Thesis, Univ. of Sevilla, Sevilla, 242 pp. 
Hermosln, M.C., Cornejo, J., White, J.L. and Hem, S.L., 1981. Sepiolite, a potential excipient for 
drugs subject to oxidative degradation. J. Pharm. Sci., 70: 189-192. 
McGinity, J.W. and Lach, J.L., 1977. Sustained-release pplications ofmontmorillonite interac- 
tion with amphetamine sulphate. J Pharm. Sci., 66: 63-66. 
Porubcan, L.S., Serna, C.J., White, J.L. and Hem, S.L., 1978. Mechanism of adsorption of clin- 
damycine and tetracycline by montmorillonite. J. Pharm. Sci., 67: 1081-1087. 
Porubcan, L.S., Born, G.S., White, J.L. and Hem, S.L., 1979. Interaction of digoxin and mont- 
morillonite: mechanism of adsorption and degradation. J. Pharm. Sci., 68: 358-361. 
SAnchez-Camazano, M. Sfinchex, M.J., Vicente, M.T. and Domlnguez-Gil, A., 1980a. Adsorption 
of Clorpheniramine Maleate by Montmorillonite. Int. J. Pharm., 6:243-251. 
S~nchez-Camazano, M., Sfinchez, M.J., Vicente, M.T. and Domfnguez-Gil, A., 1980b. IR and X- 
ray diffraction study of chlorpheniramine maleate-montmorillonite i teraction. J. Pharm. Sci., 
69: 1142-1144. 
SAnchez-Camazano, M. Sdnchez-Mart~n, M.J., Vicente, M.T. and Domfnguez-Gil, A., 1987. Ad- 
sorption-desorption of sotalol hydrochloride by Na-montmorillonite. Clay Miner., 22: 121- 
128. 
Wai, K.N., Dekay, H.G. and Banker, G.S., 1966. Applications of the montmorillonite in tablet 
making. J. Pharm. Sci., 55: 1244-1248. 
